Although altered homeostatic regulation, including disturbance of 24-hour rhythms, is often observed in the patients undergoing glucocorticoid therapy, the mechanisms underlying the disturbance remains poorly understood. We report here that chronic treatment with a synthetic glucocorticoid, prednisolone (PSL), can cause alteration of circadian clock function at molecular level. Treatment of cultured hepatic cells (HepG2) with PSL induced expression of Period1 (Per1), and the PSL treatment also attenuated the serum-induced oscillations in the expression of Period2 
and the PSL treatment also attenuated the serum-induced oscillations in the expression of Period2 
INTRODUCTION
Many biological processes in mammals are subject to daily oscillations, and some of these are controlled by self-sustained oscillation mechanism called circadian clock. This machinery operates at cellular levels and coordinates a wide variety of physiological processes and behavioral activities (1) (2) (3) . Recent molecular dissection of the circadian biological clock system has revealed that oscillation in the transcription of specific clock genes plays a central role in the generation of circadian rhythms. Gene products of Clock and Bmal1 form a heterodimer that activates the transcription of Period (Per) and Cryptochrome (Cry) genes. Once the PER and CRY proteins have reached a critical concentration, they attenuate CLOCK/BMAL1 transactivation thereby generating a circadian oscillation in their own transcription (4, 5) . The clock genes, consisting of the core oscillation loop, control downstream events by regulating the expression of clock-controlled output genes. Namely, CLOCK:BMAL1 heterodimers act through an E-box element of the output genes to activate the transcription, and the activation is inhibited by PER and CRY proteins (6, 7) . The expression of the clock genes is also modulated by a second oscillation loop composed of the two r orphan nuclear receptors, REV-ERBα and RORa, which drive a circadian oscillation in Bmal1 transcription (8, 9) .
In mammals, the master clock in the suprachiasmatic nuclei (SCN) of the anterior hypothalamus is entrained to a 24-hr period by daily light-dark cycle. The master clock, in turn, synchronizes circadian oscillators in peripheral tissues through neural and/or humoral signals (10) .
Recently, it has been reported that retinoic acids, epidermal growth factor receptor, and glucocorticoid hormones function as humoral factors for resetting the peripheral oscillators (11) (12) (13) .
Among these substances, glucocorticoids have been considered to be particularly well suited for Zeitgeber for peripheral clocks. In fact, daily rhythm of glucocorticoid secretion is controlled by the hypothalamus-pituitary-adrenal axis, which in turn is regulated by the SCN (14, 15) . Furthermore, a single administration of dexamethasone, a glucocorticoid receptor agonist, strongly induces phase shift of clock gene expression in peripheral tissues (13) . These facts suggest that circadian secretion of glucocorticoid hormone acts to synchronize peripheral clocks with the central SCN pacemaker.
Circadian clock system is necessary to adapt endogenous physiological functions to daily variations in environmental conditions. Abnormality in circadian rhythms, such as the sleep-wake cycle and the timing of hormonal secretions, is implicated in various physiological and psychiatrical disorders (16, 17) . Although a large number of synthetic glucocorticoid are frequently used clinically as immunosuppressive or anti-allergic agents, it remains poorly understood how the chronic treatment with synthetic glucocorticoid influences the circadian organization of mammalian clockwork.
In this study, we show that chronic treatment with synthetic glucocorticoid can alter the circadian clock function at molecular levels. Continuous administration of prednisolone (PSL), one of the most frequently used synthetic glucocorticoid for prolonged therapy, repressed the oscillation in the expression of clock genes in peripheral tissues of mice without changing the central SCN clockwork. The action of PSL on Per1 expression appears to have altered directly the molecular clock function in the peripheral cells. Because effectiveness and/or toxicity of many drugs vary according to their administration time, we explored the possibility that the alteration of clock function induced by glucocorticoid therapy could be overcome by optimizing the dosing schedule.
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RESULTS
The effect of PSL on the expression of clock genes in cultured hepatic cells. We first explored how chronic treatment with glucocorticoid affects the expression of circadian clock genes in cultured hepatic cells (HepG2). Because a brief exposure of cultured fibroblasts to dexamethasone causes transient Period1 (Per1) expression (13), we examined the influence of PSL on Per1 mRNA levels. As shown in Fig. 1A , treatment of HepG2 cells with PSL for 72 hr resulted in an accumulation of Per1 mRNA in a concentration-dependent manner; the most significant accumulation was seen at a concentration of 0.5 µM. Dexamethasone also produced a similar concentration-dependent accumulation of Per1 mRNA (data not shown).
Glucocorticoids exert their action on gene expression through activation of cytoplasmic glucocorticoid receptors (GRs) that bind to glucocorticoid response elements (GREs). A consensus sequence of GRE is located at -2093 to -2079 (AGAACATGATGTTCC) in the 5'-flanking region of human Per1 gene (18) . The GER sequence was also found at a similar location in mouse Per1 gene (AGAACACGATGTTCC). We therefore investigated whether PSL can directly activate the transcription of Per1 gene. To this end, we performed in vitro transient transcription assays using Per1-luciferase reporter constructs driven by the 2207-bp mouse Per1 promoter (Fig. 1B upper   panel) . Treatment of the Per1 luciferase reporter vector-transfected HepG2 cells with 0.5 µM PSL for 48 hr resulted in a 7.8-fold increase in the transcriptional activity (Fig.1B lower panel) . This PSL-induced transactivation was thought to be dependent on the GRE, because a mutation of the AGAACACGATGTTCC sequence to AGAACACGATGGCTC decreased the transcriptional activity from 7.8-fold to 2.1-fold.
We also explored whether the PSL-induced accumulation of Per1 mRNA was caused by changing the stability of Per1 mRNA transcripts. HepG2 cells were incubated for 48 hr in the 5 presence or absence of 0.5 µM PSL. Then 10 µg/ml of actinomycin D (AcD) was added to the media, and total RNA was extracted at selected time intervals. In vehicle-treated cells, the half-life of Per1 mRNA was approximately 2.98 hr (Fig.1C) . However, the half-life was not obviously prolonged during exposure of the cells to PSL (3.07 hr). Taken together, these results suggest that the PSL-induced accumulation of Per1 mRNA occurs at the transcriptional level rather than as a result of altered mRNA stability
The chronic treatment with PSL also increased PER1 protein abundance in cultured hepatic cells ( Fig Per2 and Rev-erbα were suppressed by cotransfection with PER1, whereas cotransfection of Bmal1 luciferase reporter with PER1 caused a 2.1-fold increase in the promoter activity. Because overexpression of PER1 had no significant effect on the half-lives of Per2, Rev-erbα, and Bmal1 mRNAs (Fig. 2D) , the PSL-induced accumulation of PER1 seems to modulate the expression of other clock genes at transcriptional level rather than as a result of altered their mRNA stabilities.
Influence of chronic treatment with PSL on the rhythmic expression of clock genes. We next examined how chronic treatment with PSL affects the rhythmicity of clock gene expression. The oscillation in the expression of clock genes in cultured hepatic cells was triggered by a 2-hr treatment with 50% horse serum. Thereafter the cells were incubated in the presence or absence of 0.5 µM PSL. In control cells, which were incubated in the absence of PSL after serum treatment, mRNA levels of Per1, Per2, Rev-erbα, and Bmal1 showed obvious circadian oscillations ( Fig. 3A and C). The expression patterns of clock genes were similar to those reported previously in rat-1 fibroblasts and vascular smooth muscle cells (11, 19) . By contrast, chronic treatment of the serum-treated cells with 0.5 µM PSL decreased the amplitude of oscillations in clock gene expression. The levels of Per1 and Bmal1 mRNA were gradually increased during this treatment period, whereas the oscillations in the levels of Per2 and Rev-erbα mRNAs were severely damped ( (Fig, 3D) . Although the time-dependent variations in clock gene expression were disappeared when the random ODN-transfected cells were incubated in the presence of PSL after the serum treatment, the inhibitory effects of PSL on the oscillations in the expression of clock genes were not observed in PER1 down-regulated cells (Fig. 3B) . The clock gene expression patterns in PSL-treated PER1 down-regulated cells were similar to those observed in control cells. These results suggest that PSL-induced accumulation of PER1 proteins influences the rhythmic expression of other clock genes.
Changing the dosing schedule minimizes the disruptive effect of PSL on circadian clock function. Because continuous administration of PSL into mice modulated not only the circadian gene expression in peripheral tissues but also rhythmicity in locomotor activity and body temperature ( Fig. 4 and Supplemental Fig. S2 ), we examined whether the alteration of clock function induced by PSL could be overcome by optimizing the dosing schedule. To this end, we 8 subcutaneously administrated a single dose of PSL (5mg/kg, s.c.), or vehicle (0.5% DMSO in saline) as a control, at ZT0 or ZT12 daily for 7 days. The expression rhythms of mRNAs of clock genes in liver were assessed on day 7 after initiation of the drug treatment. Although the repetitive administration of PSL at ZT0 substantially altered the mRNA rhythms of Per1, Per2, Rev-erbα, and Bmal1 in liver, the administration of PSL at ZT12 had no significant effect on the rhythms of clock genes (Fig. 5) .
Consistent with its dosing-schedule-dependent effect on the circadian clock gene expression, the repetitive administration of PSL at ZT0 modulated the daily rhythm of locomotor activity and body temperature ( Although the rhythmic expression of mRNA of clock genes in peripheral cells were changed in response to glucocorticoid stimuli, our present findings indicate that the peripheral oscillators would be less susceptible to exogenous glucocorticoid stimuli, when the glucocorticoid levels are endogenously increased. In nocturnally active rodents, the secretion of glucocorticoid hormones peaks from the late light phase to the early dark phase (14) . The cyclic elevation of circulating glucocorticoid levels is thought to synchronize the oscillation in the expression of clock genes in peripheral cells. Therefore, the exogenous administration of PSL into mice at ZT0 may have impaired the endogenous nature of glucocorticoid rhythm, and altered clock gene expression in 11 their peripheral tissues. This may account for the fact that the disruptive effect of PSL on molecular clock function in peripheral cells can be lessened by choosing the optimum time for giving the dose.
Our results suggest that alteration of molecular clock function by PSL is underlying the cause of adverse effects of glucocorticoid treatment on daily rhythms in physiology and behavior. The alteration of clock function seems to be elicited by the direct action of PSL on Per1 gene. Altered homeostatic regulation, including the disturbance of the 24-hour rhythms, is often observed in patients in chronic glucocorticoid therapy (27) (28) (29) (30) . Our present finding may extend to understanding how chronic treatment with glucocorticoids modulates the molecular organization of circadian clockwork.
MATERIALS AND METHODS
Materials. PSL sodium succinate was purchased from Sigma Chemical (St. Louis, MO), dissolved in sterilized saline containing 5% dextrose for treatment. The plasmids containing the mouse Per1 (GenBank accession number AB002108) were constructed as described previously (26) . Determination of locomotor activity. Locomotor activity was measured using photobeam activity monitoring system (Muromachi Kikai, Co. Ltd., Tokyo, Japan), and activity count (number of movements) was recorded at 0.5 hr intervals. The activity records were double-plotted so that each day's activity is shown both to the right and below that of the previous day's. For visualization of locomotor activity rhythm, hourly activity counts were calculated using a moving average with a 4-hour window.
Determination of body temperature. A lubricated thermocouple was inserted 1.5 cm into the rectum of mice and the rectal temperature was determined using a digital thermometer (BAT-12, Bio Research Center, Tokyo, Japan).
Statistical analysis. The significance of the 24-hour variation in each parameter was tested by analysis of variance (ANOVA). The statistical significance of differences among groups was analysed by ANOVA and the Tukey multiple comparison test. A 5% level of probability was considered to be significant. Rev-erbA 
